title: Indomethacin blunts the late phase of nitroglycerin-induced coronary vasodilatation in dogs.
authors.forename: B
authors.initials: B
authors.lastname: Trimarco
authors.forename: C
authors.initials: C
authors.lastname: Patrono
authors.forename: B
authors.initials: B
authors.lastname: Ricciardelli
authors.forename: M
authors.initials: M
authors.lastname: Volpe
authors.forename: A
authors.initials: A
authors.lastname: Cuocolo
authors.forename: A
authors.initials: A
authors.lastname: De Simone
authors.forename: M
authors.initials: M
authors.lastname: Condorelli
mesh_terms: D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D003331:Coronary Vessels / Q000187:drug effects*; D016861:Cyclooxygenase Inhibitors; D004285:Dogs; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D007213:Indomethacin / Q000008:administration & dosage / Q000494:pharmacology*; D007269:Injections, Intra-Arterial; D008297:Male; D009288:Naproxen / Q000008:administration & dosage / Q000494:pharmacology; D005996:Nitroglycerin / Q000008:administration & dosage / Q000494:pharmacology*; D013929:Thromboxane B2 / Q000097:blood; D014664:Vasodilation / Q000187:drug effects*
chemical_list: D016861:Cyclooxygenase Inhibitors; D013929:Thromboxane B2; D009288:Naproxen; D005996:Nitroglycerin; D007213:Indomethacin